Learn why neurologists wish they could prescribe experimental solanezumab to 15% of their Alzheimer’s patients. Solanezumab is Eli Lilly’s exciting, maturing attempt to create a
VIDEO + ARTICLE IVIG is an FDA-Approved medication. It has been prescribed off-label for Alzheimer’s. Despite recent failures in clinical trials, pharmaceutical companies and academic
A new experimental drug may rescue brain cells just as they begin to become impaired, stopping Alzheimer’s before it is even noticeable. Learn why researchers
Using Deep Brain Stimulation to treat Alzheimer’s is starting to take off. More patients are being added to clinical trials. Learn about the U.S. FDA’s
News on bexarotene demands explaining. In the Alzheimer’s lab, this FDA-approved anti-cancer drug improves memory. Since that is what matters to people, funding is pouring
RADIO & ARTICLE Hear Ronald Peterson, head of the U.S. government’s National Alzheimer’s Project Act, explore the results of 4 new studies on bexarotene (Brand
VIDEO Kathy Sanford is the first person in the USA to have a pacemaker implanted in her brain to treat Alzheimer’s. The pacemaker sends electronic
Dr. Francis Collins, director of the National Institutes of Health (NIH), just gave Americans a dose of good news on Alzheimer’s research. Find out what
Targacept is taking a confident approach in its latest clinical trial. Rather than pitting their new Alzheimer’s drug against a placebo, they are putting it
VIDEO & ARTICLE Bexarotene is an FDA-approved anti-cancer drug available under the brand name Targretin®. It clears Alzheimer’s biomarkers in mice like a charm. See
CELEBRITY VIDEO + ARTICLE: Get the word out about Alzheimer’s & Brain Awareness Month. Raise awareness of the Alzheimer’s crisis, educate people on its realities, and help people live well with dementia.
[Father’s Day is June 15]
This bride’s father has dementia. On her wedding day, she triggers his memory with an activity they shared in her childhood. See what happens.
Lecanemab (marketed as Leqembi) is today’s top Alzheimer’s drug. Why does equitable access to this drug remain a significant challenge? What needs to be done?
What are the early symptoms of Alzheimer’s? When to get a professional evaluation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
No spam, only news and updates.
